ArticleEJHaem2026

Allogeneic Hematopoietic Cell Transplantation for Relapsed or Refractory Mantle Cell Lymphoma: Real-World Outcomes, Late Relapse Patterns, and Clinical Utility in the Chimeric Antigen Receptor T-Cell Era.

Enver Aydilek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.